Clinical Trial Update: Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab with combination chemotherapy as first-line therapy for unresectable metastatic colorectal cancer. Completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Institut Bergonié | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-04-20